AusPAR: Livtencity

Australian Public Assessment Report

AusPAR

AusPAR: Livtencity [PDF, 2.08 MB]

AusPAR: Livtencity [Word, 3.91 MB]

AusPAR Attachment 1: Product Information for Livtencity [PDF, 356.78 KB]

AusPAR Attachment 1: Product Information for Livtencity [Word, 107.65 KB]

Device/Product Name

Livtencity

Active ingredients

Maribavir

AusPAR Date

25 May 2023

Published

6 June 2023

Submission Number

PM-2021-05396-1-2

Submission Type

New chemical entity

Decision

Approved